SILO PHARMA, INC. Proceeds from Notes Payable
SILO PHARMA, INC. (SILO) reported Proceeds from Notes Payable of $60.00 thousand for the 1-month period ending 2021-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-08-13
- SILO PHARMA, INC. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- SILO PHARMA, INC. proceeds from notes payable for the quarter ending 2020-09-30 was $0.00.
- SILO PHARMA, INC. proceeds from notes payable for the quarter ending 2013-09-30 was $0.00.
- SILO PHARMA, INC. proceeds from notes payable for the quarter ending 2012-12-31 was $5.00K.
- SILO PHARMA, INC. proceeds from notes payable for fiscal 2020 was $18.90K.
- SILO PHARMA, INC. proceeds from notes payable for fiscal 2012 was $20.00K.
| Period end | Proceeds from Notes Payable | Proceeds from Notes Payable 1 month | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 21 month | Proceeds from Notes Payable 24 month | Proceeds from Notes Payable 27 month | Proceeds from Notes Payable 30 month | Proceeds from Notes Payable 33 month | Proceeds from Notes Payable 36 month | Proceeds from Notes Payable 39 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $60.00K 10-Q · filed 2024-08-13 | $60.00K 10-Q · filed 2023-11-13 | |||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $18.90K 10-K · filed 2022-03-28 | ||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $18.90K 10-Q · filed 2021-11-10 | |||||||||||
| 2020-06-30 | $18.90K 10-Q · filed 2021-08-13 | ||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 39 month − 10-Q 36 month · filed 2013-11-14 | $20.00K 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $20.00K 10-Q · filed 2013-08-08 | ||||||||||||
| 2013-03-31 | $20.00K 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.00K derived: sum of 2 quarters · filed 2014-03-31 | $5.00K derived: sum of 3 quarters · filed 2014-03-31 | $20.00K 10-K · filed 2014-03-31 | $20.00K 10-K · filed 2013-03-05 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $15.00K 10-Q · filed 2013-11-14 | $15.00K 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $15.00K 10-Q · filed 2013-08-08 | $15.00K 10-Q · filed 2012-08-01 | ||||||||||
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-15 | $15.00K 10-Q · filed 2012-05-15 | |||||||||||
| 2012-02-29 | $15.00K 10-Q · filed 2012-11-13 | ||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $0.00 10-Q · filed 2012-08-01 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |